COMPANY PROFILE

Bovie Medical Corp. is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented plasma-based surgical product. J-Plasma® utilizes a gas ionization process that produces a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. J-Plasma®, still in the early stages of commercialization, has the potential to be a transformational product for surgeons.

Bovie Medical is also a leader in the manufacture of a range of electrosurgical products and technologies. These are marketed through both private labels and Bovie’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

CORPORATE INFORMATION

Executive Offices: Bovie Medical Corporation
4 Manhattanville Road  |  Purchase, NY 10577 • USA
Ph +1-914-468-4070

United States Headquarters: Bovie Medical Corporation
5115 Ulmerton Road  |  Clearwater, FL 33760-4004 • USA
Ph +1-727-384-2323

BOARD OF DIRECTORS

Andrew Makrides, Esq., Executive Chairman of the Board of Directors | Bio
Robert L. Gershon, Chief Executive Officer & Director | Bio
John Andres, Director | Bio
Michael Geraghty
, Director | Bio
J. Robert Saron, President & Director | Bio
Lawrence J. Waldman, CPA, Director | Bio

NEWS & PRESS RELEASES

LATEST NEWS

NEWS & PRESS RELEASE ARCHIVE

2016  |  2015  |  2014  |  2013  |  2012  |  2011  |  2010

                                        PDF DOWNLOADS

COMPANY PRESENTATIONS

COMPANY EVENTS

PowerPoint Presentation
HomeInvestRel

Management hosted a conference call on November 2, 2017 to discuss the results of the quarter. To listen to a replay of the call, click the button below.

TRANSCRIPTS

home_currenteventsthumb

Bovie Medical Corporation management will participate in the following investor conferences in November. To listen to the webcast, click the links below.

otherevents_graphic

QUARTERLY RESULTS

RESULTS

SUPPLEMENTALS

ANNUAL REPORTS

ANNUAL REPORTS

OTHER FILINGS

PROXY

XBRL FILINGS

2017

Filing Date: 11/03/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended September 30, 2017          XBRL | PDF | Link to SEC

Filing Date: 08/03/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended June 30, 2017          XBRL | PDF | Link to SEC

Filing Date: 05/15/2017 | Form Type: 10-Q | Description: FORM 10-Q for the period ended March 31, 2017          XBRL | PDF | Link to SEC

2016

Filing Date: 03/10/2017 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2016           XBRL | PDF | Link to SEC

Filing Date: 10/27/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2016           XBRL | PDF | Link to SEC

Filing Date: 08/01/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2016           XBRL | PDF | Link to SEC

Filing Date: 05/11/2016 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2016           XBRL | PDF | Link to SEC

Filing Date: 03/18/2016 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2015          XBRL | PDF | Link to SEC

2015

Filing Date: 11/5/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2015           XBRL | PDF | Link to SEC

Filing Date: 08/7/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2015          XBRL | PDF | Link to SEC

Filing Date: 05/8/2015 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2015           XBRL | PDF | Link to SEC

Filing Date: 02/27/2015 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2014         XBRL | PDF | Link to SEC 

2014

Filing Date: 11/10/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2014           XBRL | PDF | Link to SEC

Filing Date: 08/8/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2014          XBRL | PDF | Link to SEC

Filing Date: 05/15/2014 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2014           XBRL | PDF | Link to SEC

Filing Date: 05/15/2014 | Form Type: 10-K/A | Description: FORM 10-K/A FOR THE PERIOD ENDED DECEMBER 31, 2013         XBRL | PDF | Link to SEC 

Filing Date: 03/31/2014 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2013         XBRL | PDF | Link to SEC 

2013

Filing Date: 11/14/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2013          XBRL | PDF | Link to SEC

Filing Date: 09/25/2013 | Form Type: 10-Q/A | Description: FORM 10-Q/A FOR THE PERIOD ENDED JUNE 30, 2013         XBRL | PDF | Link to SEC

Filing Date: 08/14/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2013           XBRL | PDF | Link to SEC

Filing Date: 05/15/2013 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2013         XBRL  | Link to SEC

Filing Date: 04/1/2013 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2012         XBRL  | Link to SEC

2012

Filing Date: 11/14/2012 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2012          XBRL  | Link to SEC

Filing Date: 08/14/2012 | Form Type: 10-Q/A | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2012         XBRL  | Link to SEC

Filing Date: 05/15/2012 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2012          XBRL  | Link to SEC

Filing Date: 03/29/2012 | Form Type: 10-K | Description: FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2011         XBRL  | Link to SEC

2011

Filing Date: 11/14/2011 | Form Type: 10-Q | Description: FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2011          XBRL  | Link to SEC

Filing Date: 08/12/2011 | Form Type: 10-Q/A | Description: FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2011         XBRL  | Link to SEC

INVESTOR CONTACT

Executive Offices: Bovie Medical Corporation
4 Manhattanville Road  |  Purchase, NY 10577 • USA
Ph +1-914-468-4070

United States Headquarters: Bovie Medical Corporation
5115 Ulmerton Road  |  Clearwater, FL 33760-4004 • USA
Ph +1-727-384-2323

INVESTOR INQUIRIES:
investor.relations@boviemedical.com

TRANSFER AGENT CONTACT:
investor.relations@boviemedical.com

CORPORATE GOVERNANCE

Top